The DNA damage signalling kinase ATM is aberrantly reduced or lost in BRCA1/BRCA2-deficient and ER/PR/ERBB2-triple-negative breast cancer.
Tommiska J, Bartkova J, Heinonen M, Hautala L, Kilpivaara O, Eerola H, Aittomäki K, Hofstetter B, Lukas J, von Smitten K, Blomqvist C, Ristimäki A, Heikkilä P, Bartek J, Nevanlinna H.
Tommiska J, et al. Among authors: von smitten k.
Oncogene. 2008 Apr 10;27(17):2501-6. doi: 10.1038/sj.onc.1210885. Epub 2007 Nov 5.
Oncogene. 2008.
PMID: 17982490